Appointment of Dr Aravind Kumar Madala as an Additional Director of the company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Covance Softsol Limited's Board of Directors, at a meeting held on August 14, 2025, approved the appointment of Dr. Aravind Kumar Madala (DIN: 06994824) as an Additional Director, effective September 1, 2025. The appointment is subject to shareholder approval. Dr. Aravind Kumar Madala is a general physician with over 19 years of experience, having completed his graduation and post-graduation from Kasturba Medical College, Mangalore. He holds no shares in the company and is not debarred from holding directorship under any SEBI order.
The new appointee is the son of existing Director Mr. Bhaskar Rao Madala, indicating a promoter family member joining the board. This may raise governance considerations for minority shareholders, though the appointment itself is routine and subject to shareholder approval.